East Valley Family Physicians

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Liver cirrhosis1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Madrigal Pharmaceuticals, Inc.2 trials

Running trials

• Active, not recruiting

  A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

  NCT04951219· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· Phase 3· Madrigal Pharmaceuticals, Inc.· Source